Sunil Healthcare Limited reported earnings results for the fourth quarter and full year ended March 31, 2022. For the fourth quarter, the company reported sales was INR 316.82 million compared to INR 234.86 million a year ago. Revenue was INR 325.33 million compared to INR 246.74 million a year ago. Net income was INR 40.11 million compared to net loss of INR 5.98 million a year ago. Basic earnings per share from continuing operations was INR 3.91 compared to basic loss per share from continuing operations of INR 0.58 a year ago. Diluted earnings per share from continuing operations was INR 3.91 compared to diluted loss per share from continuing operations of INR 0.58 a year ago.
For the full year, sales was INR 1,191.64 million compared to INR 906.2 million a year ago. Revenue was INR 1,208.4 million compared to INR 961.99 million a year ago. Net income was INR 64.21 million compared to net loss of INR 6.38 million a year ago. Basic earnings per share from continuing operations was INR 6.26 compared to basic loss per share from continuing operations of INR 0.62 a year ago. Diluted earnings per share from continuing operations was INR 6.26 compared to diluted loss per share from continuing operations of INR 0.62 a year ago.